Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Tumori|May 7, 2016
New drugs in the treatment of elderly patients with metastatic castration-resistance prostate cancerGiovenzio Genestreti, Monica Di Battista, Giovanna Cavallo, et al.
Expert Review of Anticancer Therapy|June 2, 2015
Maintenance therapy in non-small cell lung cancerGiovenzio Genestreti, Monica Di Battista, Giovanna Cavallo, et al.
Recenti Progressi in Medicina|May 30, 2006
[Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years]Antonio Santo, Giovenzio Genestreti, Elena Fiorio, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2006
Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patientsAntonio Santo, Giovenzio Genestreti, Alberto Terzi, et al.
Journal of Neuro-Oncology|April 20, 2018
Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?Enrico Franceschi, Giuseppe Lamberti, Alexandro Paccapelo, et al.
Future Oncology (London, England)|November 15, 2014
Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overviewGiovenzio Genestreti, Francesco Grossi, Carlo Genova, et al.
Tumori|October 7, 2005
Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosisMaximilian Papi, Giovenzio Genestreti, Davide Tassinari, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Journal of Cancer|June 7, 2012
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and ChemotherapyGiovenzio Genestreti, Andrea Moretti, Sara Piciucchi, et al.
Pageof 3